<--- Back to Details
First PageDocument Content
Date: 2010-12-21 11:17:55

Washington University in St. Louis Institutional Biological & Chemical Safety Committee Policy on Severe Adverse Event Reporting for Human Gene Therapy Trials As outlined in Section IV-B-2-b-(1) of the NIH Guidelines for

Add to Reading List

Source URL: ehs.wustl.edu

Download Document from Source Website

File Size: 60,77 KB

Share Document on Facebook

Similar Documents